Target intelligence / Profile preview

Complement component 4 binding protein beta chain (C4BPB)

Target
C4BPB
Molecular classification
Regulatory complement control protein, Glycoprotein, Plasma protein, Other
01

Overview

Complement component 4 binding protein beta chain (C4BPB) is the beta subunit of the C4b-binding protein (C4BP), a key regulator of the classical and lectin pathways of complement activation in the innate immune system. In human blood, the main C4BP isoform is composed of seven alpha-chains and one unique beta-chain, forming a multimeric, spider-like protein with crucial roles in downregulating complement-mediated inflammation and injury. The beta chain specifically binds with high affinity to protein S, a vitamin K-dependent anticoagulant cofactor, linking C4BP to coagulation pathways. Through its cofactor activity with serine protease factor I, it accelerates the inactivation of the complement fragment C4b and the decay of C3 convertase complexes. C4BPB also contributes to the clearance of apoptotic and necrotic cells, interacts with various host and microbial molecules, and may be implicated in infectious disease pathogenesis and coagulation disorders[1][3][4][5].

Other names
C4b-binding protein beta chainC4BP beta chainComplement component 4 binding protein, beta chainC4BPC4BPB
02

Mechanism of action

Cofactor activity for serine protease factor I in inactivating C4b (and to a lesser extent C3b); Binding and regulation of protein S (vitamin K-dependent anticoagulant) affecting coagulation; Decay acceleration of C4bC2a complex (C3 convertase) in complement cascade[3][4][5]

03

Biological functions

Inhibition of classical and lectin pathway of complement activationRegulation of coagulation through interaction with protein SImmune response modulationBinding to apoptotic and necrotic cells for clearanceInteraction with pathogens for immune evasion[1][3][4][5]
04

Disease associations

InflammationInfection (as immune evasion by pathogens)Hemolytic uremic syndrome, atypical 1Atypical hemolytic-uremic syndromePotential involvement in coagulation disorders and autoimmune diseases[3]
05

Safety considerations

Modulating C4BPB may risk dysregulation of complement inhibition, possibly predisposing to autoimmune disorders or excessive inflammationPossible increased risk of infection if complement function is suppressedPotential to alter coagulation processes, leading to thrombotic or bleeding risks if disturbed[3][5]
06

Interacting drugs

None currently approved or widely reported targeting C4BPB directly (No evidence from current literature or clinical trial drug records)[3][4][5]
07

Biomarkers

No widely recognized clinical biomarkers based on C4BPB levels or activity currently in standard useC4BP/C4BPB levels may be measured in immune profiling or experimental biomarker research (e.g., inflammation, coagulation disorders)[2][3]

Beyond the preview

Go deeper on Complement component 4 binding protein beta chain (C4BPB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement component 4 binding protein beta chain (C4BPB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call